<DOC>
	<DOCNO>NCT01374906</DOCNO>
	<brief_summary>This randomize , double-blind , multicenter , phase III study evaluate safety efficacy 2 dosing regiment Pasireotide long act release ( LAR ) patient Cushing 's disease .</brief_summary>
	<brief_title>Efficacy Safety Pasireotide Administered Monthly Patients With Cushing 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
	<mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
	<criteria>Karnofsky performance status ≥ 60 ( i.e . require occasional assistance , able care personal need ) For patient medical treatment Cushing 's disease follow washout period must complete screen assessment perform Inhibitors steroidogenesis ( ketoconazole , metyrapone ) : 1 week Pituitary direct agent : Dopamine agonist ( bromocriptine , cabergoline ) PPARγ agonist ( rosiglitazone pioglitazone ) : 4 week Octreotide LAR , Lanreotide SR Lanreotide autogel : 14 week Octreotide ( immediate release formulation ) : 1 week Patients consider candidate surgical treatment time study entry Patients receive pituitary irradiation within last ten year prior visit 1 Patients previous pasireotide treatment Patients treat mitotane last 6 month prior Visit 1 Diabetic patient antihyperglycemic medication poor glycemic control evidence HbA1c &gt; 8 % Patients risk factor torsade de pointes , i.e . patient baseline QTcF &gt; 470 m , hypokalemia , uncontrolled hypothyroidism , family history long QT syndrome , concomitant medication know prolong QT interval Female patient pregnant lactating , childbearing potential ( defined woman physiologically capable become pregnant ) practice effective method contraception/birth control . Sexually active male must use condom intercourse take drug 2 month last dose study drug father child period . A condom require use also vasectomize men order prevent delivery drug via seminal fluid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cushing 's Disease</keyword>
	<keyword>Mean Urinary Free Cortisol</keyword>
	<keyword>Pasireotide</keyword>
</DOC>